Loading clinical trials...
Loading clinical trials...
In this multicenter study, we will recruit 400 patients 40 years of age or older at 15 centers with a diagnosis of smoldering multiple myeloma (SMM), a group of patients for whom standard of care is o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tufts Medical Center
Collaborators
NCT02269592 · Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, and more
NCT06383143 · AL Amyloidosis, Smoldering Multiple Myeloma, and more
NCT03717844 · Multiple Myeloma, Amyloidosis, and more
NCT06895291 · Lymphoma, Advanced Prostate Cancer, and more
NCT05361694 · Multiple Myeloma, Smoldering Multiple Myeloma, and more
University of Alabama Hospital
Birmingham, Alabama
Cedars-Sinai Medical Center
Los Angeles, California
University of California, San Francisco
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions